نتائج البحث 1991-2000 من 11681 لعملية البحث عن emerging infectious diseases
... disease progression, assess the need for treatment, and assess infection rates. Avelumab In Combination Regimens That Include An Immune Agonist, Epigenetic ...
A Study Of A New Molecular Approach To Blood DNA Screening For Cancer ... The goal of this study is to provide access to brexucabtagene autoleucel for patients ...
The goal of this study is to provide access to brexucabtagene autoleucel for patients diagnosed with a disease approved for treatment with brexucabtagene ...
The goals of tendinopathy treatment are to relieve pain, reduce irritation and prevent future tendon conditions. Self-care, including rest, ice and pain ...
... disease progression, assess the need for treatment, and assess infection rates. التصفّح دراسات سريرية. السابقالصفحة السابقة · توجّه للصفحة 2626 · توجّه للصفحة ...
... disease progression, assess the need for treatment, and assess infection rates. Phase 2 Trial Of Voyager V1 In Combination With Cemiplimab In Cancer ...
... disease progression, assess the need for treatment, and assess infection rates. 3D Surface Scanning. Scottsdale/Phoenix, Ariz. The purpose of this study is ...
Cochlear implant procedure, Meningioma, Acoustic neuroma, Middle ear infection, Otosclerosis, Facial paralysis ... , Alzheimer's disease ... New genetic biomarker ...
... disease, Polycystic kidney disease, Budd-Chiari syndrome, Metabolic liver disease ... Biliary stone disease ... new era of minimally invasive and endovascular ...
... Infection, Pleural effusion, Liver disease, Bone metastasis, Abscess. إظهار المزيد من مجالات التخصص من أجل John J. Schmitz, M.D. ...
لا تُقدم Mayo Clinic الدعم للشركات أو المنتجات المُعلَّن عنها هنا. لكن تدعم العائدات الإعلانية رسالتنا غير الربحية.
تحقق من هذه الكتب الأكثر مبيعًا والعروض الخاصة على الكتب والنشرات الإخبارية من Mayo Clinic Press.
تساهم التبرّعات، وهي قابلة للخصم الضريبي، في دعم آخر التطورات في الأبحاث وطرق الرعاية لإحداث نقلة نوعية في الطب.